InVitria

InVitria is a global leader in developing and manufacturing high-performance, animal-origin-free cell culture supplements and recombinant proteins. Our products eliminate human and animal serum-derived components to improve consistency, reduce regulatory burden, and accelerate the approval of life-changing therapies. Trusted in clinical and commercial production of cell and gene therapies, vaccines, regenerative medicine, and medical devices, InVitria supports cGMP and ISO-compliant manufacturing aligned with FDA and EMA expectations. Scalable to meet growing global demand, our chemically defined solutions enable safer, more efficient biomanufacturing.